CCND1 Split CISH Probe is designed for the qualitative detection of translocations involving the human CCND1 gene at 11q13.3 in formalin-fixed, paraffin-embedded specimens by chromogenic in situ hybridization (CISH).
Recommend Usage:
The product is ready-to-use. No reconstitution, mixing, or dilution is required. Bring probe to room temperature (18-25°C) and mix briefly before use.
Supplied Product:
Reagent Provided:This Probe is composed of:1. Digoxigenin-labeled polynucleotides, which target sequences mapping in 11q13.3* (chr11:68,522,105-68,705,283) proximal to the CCND1 breakpoint region.2. Dinitrophenyl-labeled polynucleotides, which target sequences mapping in 11q13.3* (chr11:69,453,301-70,031,240) distal to the CCND1 breakpoint region. 3. Formamide based hybridization buffer.*according to Human Genome Assembly GRCh37/hg19
Storage Instruction:
Store at 2-8°C in an upright position. Return to storage conditions immediately after use.
Note:
The probe is intended to be used in combination with the CISH Implementation Kit 2 (Catalog #: KA5366), which provides necessary reagents for specimen pretreatment and post-hybridization processing.Interpretation of results:Using the CISH Implementation Kit 2 (Cat # KA5366), hybridization signals of Digoxigenin-labeled polynucleotides appear as dark green colored distinct dots (proximal to the CCND1 breakpoint region), and Dinitrophenyllabeled polynucleotides appear as bright red colored distinct dots (distal to the CCND1 breakpoint region).Normal situation: In interphases of normal cells or cells without a translocation involving the CCND1 gene region, two red/green fusion signals appear.Aberrant situation: One CCND1 gene region affected by a translocation is indicated by one separate green signal and one separate red signal.Overlapping signals may appear as brown signals. Genomic aberrations due to small deletions, duplications or inversions might result in inconspicuous signal patterns. Other signal patterns than those described above may be observed in some abnormal samples. These unexpected signal patterns should be further investigated.
Probe Position:
Regulatory Status:
For research use only (RUO)
Interpretation of Result:
Datasheet:
Download
Applications
Chromogenic In Situ Hybridization (FFPE Tissue)
Mantle cell lymphoma tissue section with translocation affecting the 11q13.3 locus as indicated by one non-rearranged red/green fusion signal, one red signal, and one separate green signal indicating the translocation.
Application Image
Chromogenic In Situ Hybridization (FFPE Tissue)
enlarge
Gene Information
Entrez GeneID:
595
Gene Name:
CCND1
Gene Alias:
BCL1,D11S287E,PRAD1,U21B31
Gene Description:
cyclin D1
Omim ID:
151400, 168461, 193300, 254500
Gene Ontology:
Hyperlink
Gene Summary:
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq
Other Designations:
B-cell CLL/lymphoma 1,G1/S-specific cyclin D1
Gene Pathway
Acute myeloid leukemia
Bladder cancer
Cell cycle
Chronic myeloid leukemia
Colorectal cancer
Endometrial cancer
Focal adhesion
Glioma
Jak-STAT signaling pathway
Melanoma
Non-small cell lung cancer
p53 signaling pathway
Pancreatic cancer
Pathways in cancer
Prostate cancer
Small cell lung cancer
Thyroid cancer
Wnt signaling pathway
Related Disease
Adenocarcinoma
Adenocarcinoma, Mucinous
Adenoma
Ataxia telangiectasia
Barrett Esophagus
Brain Neoplasms
Breast cancer
Breast Neoplasms
Breast Neoplasms, Male
Carcinoma
Carcinoma in Situ
Carcinoma, Basal Cell
Carcinoma, Hepatocellular
Carcinoma, Non-Small-Cell Lung
Carcinoma, Renal Cell
Carcinoma, Squamous Cell
Carcinoma, Transitional Cell
Cell Transformation, Neoplastic
Cell Transformation, Viral
... see more
Chromosome Aberrations
Chronic Disease
Colitis, Ulcerative
Colon cancer
Colorectal Neoplasms
Colorectal Neoplasms, Hereditary Nonpolyposis
Crohn Disease
Disease Progression
Disease Susceptibility
DNA Damage
Endometrial Neoplasms
Esophageal Neoplasms
Fetal Diseases
Gastritis
Gastroesophageal Reflux
Genetic Predisposition to Disease
Genomic Instability
Glioma
Head and Neck Neoplasms
Helicobacter Infections
Hematologic Diseases
Hemophilia A
Hemophilia A
Hepatoblastoma
Hodgkin Disease
Hyperparathyroidism
Hypopharyngeal Neoplasms
Inflammatory Bowel Diseases
Insulin Resistance
Intestinal Neoplasms
Kidney Failure, Chronic
Kidney Neoplasms
Laryngeal Diseases
Laryngeal Neoplasms
Leiomyoma
Leukemia, Lymphocytic, Acute
Leukemia, Lymphocytic, Acute, L1
Leukemia, Lymphocytic, Chronic
Leukoplakia, Oral
Liver Neoplasms
Lung Neoplasms
Lymphatic Metastasis
Lymphoma, B-Cell
Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Meningeal Neoplasms
Meningioma
Mouth Neoplasms
Nasopharyngeal Neoplasms
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasms
Neoplasms, Ductal, Lobular, and Medullary
Neoplasms, Glandular and Epithelial
Neoplasms, Radiation-Induced
Neuroma, Acoustic
Obesity
Occupational Diseases
Oropharyngeal Neoplasms
Ovarian cancer
Ovarian Neoplasms
Papillomavirus Infections
Peptic Ulcer
Pituitary Neoplasms
Precancerous Conditions
Prolactinoma
Prostate cancer
Prostatic Hyperplasia
Prostatic Neoplasms
Pulmonary Disease, Chronic Obstructive
Rectal Neoplasms
Recurrence
Retinoblastoma
Skin Neoplasms
Stomach Neoplasms
Translocation, Genetic
Urinary Bladder Neoplasms
Uterine Cervical Neoplasms
Uterine Neoplasms
Waldenstrom Macroglobulinemia
Werner syndrome
... hidden
Related Product
DI0556
CDK4 & CCND1 Protein Protein Interaction Antibody Pair
DI0557
GSK3B & CCND1 Protein Protein Interaction Antibody Pair